Company News: Pfizer (PFE) quarterly earnings beat analysts’ estimate

Market news

29 July 2019

Company News: Pfizer (PFE) quarterly earnings beat analysts’ estimate

Pfizer (PFE) reported Q2 FY 2019 earnings of $0.80 per share (versus $0.77 in Q2 FY 2018), beating analysts’ consensus estimate of $0.75.

The company’s quarterly revenues amounted to $13.264 bln (-1.5% y/y), missing analysts’ consensus estimate of $13.430 bln.

The company also lowered guidance for FY 2019: it projected EPS of $2.76-2.86 (prior $2.83-2.93) versus analysts’ consensus estimate of $2.91 and revenues of $50.5-52.5 bln (prior $52-54 bln) versus analysts’ consensus estimate of $53.45 bln.

PFE fell to $42.15 (-2.18%) in pre-market trading.

BoE will likely retain its hiking bias - TDS

Donald J. Trump@realDonaldTrump: "The E.U. and China will further lower interest rates and pump money into their systems", while "our Fed does nothing"

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.